Table 1

Baseline characteristics of study participants

Total study population
n=204 (%)
Hospital-based management
n=101 (%)
Home-based management
n=103 (%)
Patient characteristics
Patient age (median, IQR)36.5 (30.0–44.0)37.0 (30.0–44.0)36.0 (30.0–43.0)
Patient sex (% male)142 (69.6)77 (74.8)65 (64.4)
TB class
 Pulmonary182 (89.2)84 (83.2)98 (95.2)
 Extrapulmonary22 (10.78)17 (16.8)5 (4.8)
TB category*
 Relapse99 (48.5)44 (43.6)55 (53.4)
 TALTFU5 (2.5)2 (2.0)3 (2.9)
 Fail15 (7.4)5 (5.0)10 (9.7)
 Other85 (41.7)50 (49.5)35 (34.0)
Sputum culture positive80 (39.2)38 (37.6)42 (40.8)
HIV positive164 (80.4)87 (86.1)77 (74.8)
Established on ART if HIV positive131 (80.9)70 (81.4)61 (80.26)
CD4 count (cells/mm3; median, IQR)177 (82–423)161 (68–339)225 (117–560)
No of previous TB episodes
 1174 (85.3)88 (87.1)86 (83.5)
 228 (13.7)12 (11.9)16 (15.5)
 >22 (1.0)1 (1.0)1 (1.0)
Baseline Karnofsky Score (median, IQR)90 (80–100)90 (80–90)90 (90–100)
History of alcohol excess†47 (23.7)21 (21.1)26 (26.3)
Guardian characteristics
Guardian age (median, IQR)32 (26–40)33 (28–39)30 (25–40)
Guardian sex (% male)62 (30.4)28 (27.7)34 (33.0)
Guardian level of education
 None4 (2.0)4 (4.0)0 (0.0)
 Standard 1–433 (16.2)20 (19.8)13 (12.6)
 Standard 5–852 (25.5)26 (25.7)26 (25.2)
 Form 1–242 (20.6)18 (17.8)24 (23.3)
 Form 3–445 (22.1)20 (19.8)25 (24.3)
 University28 (13.7)13 (12.9)15 (14.6)
Guardian relationship to patient
 Spouse74 (36.3)37 (36.6)37 (35.9)
 Sibling56 (27.5)28 (27.7)28 (27.2)
 Parent16 (7.8)9 (2.9)7 (6.8)
 Child19 (9.3)7 (6.9)12 (11.7)
 Aunt/uncle14 (6.9)7 (6.9)7 (6.8)
 Niece/nephew9 (4.4)3 (3.0)6 (5.8)
 Friend/neighbour16 (7.8)10 (9.9)6 (5.8)
  • *Standard WHO definitions of TB category: relapse=a patient previously treated for TB, declared cured or treatment completed, who is diagnosed again with smear or culture-positive TB; treatment after failure=a patient who is started on retreatment regimen after having failed previous treatment; treatment after loss to follow-up (TALTFU)=a patient who returns to treatment, positive bacteriologically, following interruption of treatment for 2 or more consecutive months; other previously treated=all previously treated cases that do not fit any of the above definitions http://www.who.int/tb/err/rr_final_forms_en.pdf.

  • †As defined by the Alcohol Use Disorders Identification Test.36